Back to top

Kairos Pharma announces collaboration with Bayer to enhance XOFIGO

Kairos Pharma (KAPA) announced a strategic collaboration with Bayer (BAYRY) to evaluate Kairos Pharma’s lead antibody ENV-105, a first-in-class CD1...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)